STEPHANY RUSZALA: Open Payments
NPI 1679253223 · NORTH TONAWANDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,391 in 78 payments from 18 companies in 2025. Trend: 2023 $895 · 2024 $2,106 · 2025 $1,391
Food & beverage: $1,391
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $228 |
| Amgen Inc. | 16 | $193 |
| AstraZeneca Pharmaceuticals LP | 8 | $192 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $165 |
| Lilly USA, LLC | 9 | $148 |
| GlaxoSmithKline, LLC. | 5 | $92 |
| ABBVIE INC. | 2 | $51 |
| Verona Pharma, Inc. | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| SHIELD THERAPEUTICS INC | 2 | $34 |
Products named: JARDIANCE, OTEZLA, AIRSUPRA, TRELEGY ELLIPTA, MOUNJARO, Wegovy, UBRELVY, Ohtuvayre.
Industry payments across NY — which companies pay providers there.
